Print

Amarin Corporation PLC (AMRN) to Present at the 31st Annual J.P. Morgan Healthcare Conference  
1/3/2013 9:08:31 AM

BEDMINSTER, N.J., and DUBLIN, Ireland, Jan. 2, 2013 (GLOBE NEWSWIRE) -- Amarin Corporation plc (Nasdaq:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced that Joseph Zakrzewski, Amarin's Chairman and Chief Executive Officer, is scheduled to present a company update at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2013, at 11:30 a.m. PT. This conference will be held at the Westin St. Francis Hotel in San Francisco, California.
//-->